The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vramath Financial Services Pvt Ltd & PACs
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.8 pts more than Nifty Microcap 250 and 2.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vramath Financial Services Private Limited, along with Persons Acting in Concert (PACs), has disclosed the acquisition of 20,84,835 equity shares (10.02%) of Lotus Eye Hospital and Institute Limited through open market purchases. The acquirer and PACs held 3,58,818 shares (1.73%) before this acquisition and bought an additional 17,26,017 shares (8.30%), taking their total holding to 10.03% post-acquisition. The acquirer has confirmed it does not belong to the Promoter/Promoter Group of the company. The acquisition date is 02/02/2026 and the target company's total equity share capital stands at 2,07,96,330 shares. The disclosure was filed under Regulation 29(1) of SEBI SAST Regulations, triggered by crossing the 10% substantial holding threshold.
This is a significant non-promoter acquisition crossing the 10% substantial holding mark, which means the acquirer and PACs will need to make an open offer if they cross 25% under SAST norms. For retail investors, this signals a new sizeable stakeholder entering the company, which could bring governance changes or activist pressure going forward.